Neoadjuvant chemotherapy as ovarian cancer treatment: ever more used with major regional differences

Carsten L Fagö-Olsen; Bent Ottesen; Henrik Kehlet; Algirdas Markauskas; Berit J Mosgaard; Christian Ottosen; Charlotte Søgaard; Erik Søgaard-Andersen; Claus Høgdall

Neoadjuvant chemotherapy as ovarian cancer treatment: ever more used with major regional differences

Carsten L Fagö-Olsen, Bent Ottesen, Henrik Kehlet, Algirdas Markauskas, Berit J Mosgaard, Christian Ottosen, Charlotte Søgaard, Erik Søgaard-Andersen, Claus Høgdall

10 Citations (Scopus)

Abstract

The traditional first-line treatment for patients with advanced ovarian cancer with primary debulking surgery (PDS) and adjuvant chemotherapy is controversial as some authors report a potential benefit from the alternative treatment with neoadjuvant chemotherapy (NACT) and interval debulking surgery. The aim of this study was to investigate the use of NACT in Denmark in regard to increased use and regional differences.

Original language	English
Journal	Danish Medical Journal
Volume	59
Issue number	8
Pages (from-to)	A4477
Number of pages	5
Publication status	Published - 2012

Access to Document

http://www.ncbi.nlm.nih.gov/pubmed/?term=22849978

Cite this

@article{134090302c1f46a0b7bb8162f19fd0dc,

title = "Neoadjuvant chemotherapy as ovarian cancer treatment: ever more used with major regional differences",

abstract = "The traditional first-line treatment for patients with advanced ovarian cancer with primary debulking surgery (PDS) and adjuvant chemotherapy is controversial as some authors report a potential benefit from the alternative treatment with neoadjuvant chemotherapy (NACT) and interval debulking surgery. The aim of this study was to investigate the use of NACT in Denmark in regard to increased use and regional differences.",

author = "Fag{\"o}-Olsen, {Carsten L} and Bent Ottesen and Henrik Kehlet and Algirdas Markauskas and Mosgaard, {Berit J} and Christian Ottosen and Charlotte S{\o}gaard and Erik S{\o}gaard-Andersen and Claus H{\o}gdall",

year = "2012",

language = "English",

volume = "59",

pages = "A4477",

journal = "Danish Medical Journal",

issn = "1603-9629",

publisher = "Almindelige Danske Laegeforening",

number = "8",

}

TY - JOUR

T1 - Neoadjuvant chemotherapy as ovarian cancer treatment: ever more used with major regional differences

AU - Fagö-Olsen, Carsten L

AU - Ottesen, Bent

AU - Kehlet, Henrik

AU - Markauskas, Algirdas

AU - Mosgaard, Berit J

AU - Ottosen, Christian

AU - Søgaard, Charlotte

AU - Søgaard-Andersen, Erik

AU - Høgdall, Claus

PY - 2012

Y1 - 2012

N2 - The traditional first-line treatment for patients with advanced ovarian cancer with primary debulking surgery (PDS) and adjuvant chemotherapy is controversial as some authors report a potential benefit from the alternative treatment with neoadjuvant chemotherapy (NACT) and interval debulking surgery. The aim of this study was to investigate the use of NACT in Denmark in regard to increased use and regional differences.

AB - The traditional first-line treatment for patients with advanced ovarian cancer with primary debulking surgery (PDS) and adjuvant chemotherapy is controversial as some authors report a potential benefit from the alternative treatment with neoadjuvant chemotherapy (NACT) and interval debulking surgery. The aim of this study was to investigate the use of NACT in Denmark in regard to increased use and regional differences.

M3 - Journal article

C2 - 22849978

SN - 1603-9629

VL - 59

SP - A4477

JO - Danish Medical Journal

JF - Danish Medical Journal

IS - 8

ER -

Neoadjuvant chemotherapy as ovarian cancer treatment: ever more used with major regional differences

Abstract

Access to Document

Fingerprint

Cite this